BioVie Inc.
BIVI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $57 | $57 | $0 | $0 |
| Gross Profit | -$57 | -$57 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $2,936 | $1,224 | $1,345 | $4,705 |
| G&A Expenses | $2,291 | $0 | $0 | $0 |
| SG&A Expenses | $2,291 | $2,381 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $1,643 | $2,588 |
| Operating Expenses | $5,227 | $3,606 | $2,988 | $7,293 |
| Operating Income | -$5,285 | -$3,663 | -$2,988 | -$7,293 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $153 | $174 | $200 | $180 |
| Pre-Tax Income | -$5,131 | -$3,489 | -$2,788 | -$7,113 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5,131 | -$3,489 | -$2,788 | -$7,113 |
| % Margin | – | – | – | – |
| EPS | -0.98 | 0.98 | -1.5 | -4.6 |
| % Growth | -200% | 165.3% | 67.4% | – |
| EPS Diluted | -0.98 | -1.82 | -1.5 | -4.6 |
| Weighted Avg Shares Out | 5,214 | 14,774 | 1,851 | 1,572 |
| Weighted Avg Shares Out Dil | 5,214 | 14,774 | 1,851 | 1,572 |
| Supplemental Information | – | – | – | – |
| Interest Income | $199 | $179 | $197 | $253 |
| Interest Expense | $2 | $5 | $5 | $67 |
| Depreciation & Amortization | $57 | $57 | $57 | $57 |
| EBITDA | -$5,072 | -$3,427 | -$2,931 | -$7,235 |
| % Margin | – | – | – | – |